Call 1-877-355-4447

Monday—Friday
am to 8 pm ET

Privigen Connect is an information hub for healthcare professionals (HCPs) and a resource center for patients and caregivers who depend on the immunoglobulin (Ig) therapies offered by CSL Behring.

For HCPs, our friendly and knowledgeable staff can confirm whether Privigen is a covered treatment, provide general product information, including information on coding and billing, and connect you to CSL Behring's field reimbursement team.

For patients and caregivers, Privigen Connect gathers many resources under one roof so it's easy for your patients to get the support they need with a single phone call. Our staff can also answer many non-medical, Ig-related questions and provide educational materials.

How can Privigen Connect help your patients?

Copay support Icon

Copay Support Program

  • The Copay Support Program helps eligible Privigen patients with commercial insurance by assisting with out-of-pocket expenses for Privigen, up to $20,000 in copay assistance per calendar year.
  • Most people with commercial insurance pay $0 out-of-pocket*

* Subject to terms and conditions of the copay assistance program. To read the full terms and conditions, visit CSL Copay Terms and Conditions. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.

Web Assurance Icon

Continued Treatment

  • Continued treatment for eligible patients experiencing a lapse in insurance. Contact Privigen Connect for more information

Enrollment required. Subject to terms and conditions. For the Assurance program, visit cslbehringassurance.com

PAP Icon

Patient Assistance Program

  • Provides access to therapies for qualified patients who are uninsured or underinsured
phone operator Icon

Reimbursement Support

  • Prior authorization, appeals, and connection to CSL Behring's field reimbursement team

Provide your patients with more support

See everything CSL Behring offers the PI, CIDP, and chronic ITP patient communities.

Visit patient site
You are now leaving the current website.

Do you want to continue?